Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Products>This Product

Diffinity RapidTip2 for PCR Purification with Polymerase Removal

Product Image
Product Description

Diffinity RapidTip2 for PCR Purification with Polymerase Removal

•    One Minute PCR purification
•    Effectively removes dNTPs, primers, primer-dimers, and DNA polymerase
•    High purity and yield
•    Use in downstream applications such as restriction digest, T-A cloning, and pre-Sanger sequencing reactions
•    Purifies a 50ul post-PCR sample

The new Diffinity RapidTip2 functional pipette tip contains proprietary Diffinity technology that enables fast, effective purification of PCR samples in one minute, in one step using just our RapidTip2 tip and a pipettor!

In just one simple mixing step, the RapidTip2 binds the impurities in a PCR reaction while leaving just the purified amplicon in solution.  DNA polymerase is removed to undetectable levels along with up to 90% of dNTPs, primers, and primers-dimers which bind to the technology inside of the tip.

The RapidTip2 is different than the original RapidTip for PCR purification (Pre-Sanger Sequencing) in that it's optimized for a 50ul PCR sample volume and has been tested to additionally remove standard, hot start, and proofreading DNA polymerases.

The RapidTip2 is easy to use and environmentally friendly, too.  Everything you need to purify your PCR sample is contained in the tip - no additional reagents, consumables, or energy consuming capital equipment is needed.  When you're done with your purification, just toss the tip in regular lab trash.

Product Diffinity RapidTip2 for PCR Purification with Polymerase Removal
Company Diffinity Genomics
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Diffinity Genomics
150 Lucius Gordon Drive West Henrietta, NY 14586

Tel: +1 877.362.1812
Fax: 585-272-8145

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos